KEENON Robotics, Creator of XMAN and One of the World’s Global Leaders and Largest Robotic Manufacturers, Signs Partnership Agreement With Aibotics
Rhea-AI Summary
Aibotics (OTC: AIBT), a subsidiary of Ehave (OTC: EHVVF), has announced a strategic partnership with KEENON Robotics, a Hong Kong-based global leader in service robotics. The partnership focuses on two key initiatives: potential manufacturing of Aibotics' Phill Robot™, an AI-powered massage robot, and distribution of KEENON's service robots across Israel and Jamaica.
The company is targeting Israel's $8.1 billion food service sector and Jamaica's tourism industry, which generated $2.4 billion in revenue from 2.3 million visitors in 2025. The agreement includes distribution rights for KEENON's product line, including the DinerBot series, ButlerBot W3, and KleenBot models.
The partnership positions Aibotics in the rapidly growing robotics market, with the global service robotics sector projected to reach $90-100 billion by 2032 and the humanoid robotics sector forecast to exceed $38 billion by 2035.
Positive
- Strategic partnership with KEENON Robotics, a global leader in service robotics
- Expansion into Israel's $8.1 billion food service sector and Jamaica's $2.4 billion tourism market
- Access to CARICOM region with 33 million potential customers
- Potential manufacturing partnership for Phill Robot in $1 billion massage robotics market
- Multiple revenue streams across hospitality, healthcare, retail, and security sectors
Negative
- Previous press release contained incorrect information about Singapore partnership
- Manufacturing costs and final pricing for Phill Robot still pending
- Pending acquisition of Jamaican technology company not yet finalized
- Israel partnership with CSE-listed company still to be announced
News Market Reaction 1 Alert
On the day this news was published, AIBT gained 16.67%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Aibotics is in discussions with KEENON Robotics as a potential manufacturing partner for its Phill Robot™, the first AI-powered massage robot in a massage robotics market projected to exceed
MIAMI, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Aibotics, Inc. (OTC: AIBT) (“AIBotics” or the “Company”), a developer and manager of AI- and robotics-enhanced technologies and a subsidiary of Ehave, Inc. (OTC: EHVVF), today announced it is accelerating its international expansion through a partnership with KEENON Robotics (KEENON), a Hong Kong–based global leader in service robotics. The agreement positions Aibotics to drive growth across the Middle East, beginning in Israel, and to establish Jamaica as its first foothold in the CARICOM region, home to 33 million people, through a multi-year partnership to distribute KEENON’s advanced lineup of service robots, including the DinerBot series (T8, T9, T10, T11), ButlerBot W3, and KleenBot C30 and C40, across the rapidly expanding restaurant, hospitality, retail, healthcare, and transportation sectors where rising labor costs and rapid automation adoption are driving strong revenue potential.
Aibotics plans to announce its Israel partnership with a publicly traded company listed on the Canadian Securities Exchange in the near future, aiming to drive growth in the hospitality technology sector. In Jamaica, Aibotics intends to acquire a technology company with established contracts across the tourism industry and with key government agencies, including the coast guard, fire brigade, and military forces.
Israel’s food service sector generated about
Jamaica’s economy is anchored by tourism and hospitality. In 2025, the island welcomed 2.3 million visitors, generating
Progress is being made to bring Phill Robot to market and KEENON Robotics has received all technical specifications for the production of Aibotics’ AI-powered massage robot. KEENON is preparing a comprehensive quote covering parts, service, warranty, and total unit costs for 2025.
The massage robot remains a strong growth opportunity for Aibotics shareholders. Globally, the smart home market is projected to grow from
Higher labor costs and limited skilled staff in resorts and restaurants are pushing automation for efficiency. Healthcare facilities are looking to robots for safe, cost-effective support, while retail outlets are adopting smart systems to enhance experiences. Transportation hubs, particularly airports, are prime opportunities for deployment. Jamaica also serves as a launch point into CARICOM, where success can scale adoption across the 15-member bloc.
Ben Kaplan, CEO of Aibotics, said, “This partnership with KEENON Robotics marks a pivotal step in Aibotics’ international expansion strategy. By partnering with KEENON, we are delivering world-class robotics to markets eager for automation across hospitality, healthcare, and retail.” Mr. Kaplan continued, “We are also advancing discussions with security robotics companies, a sector projected to surpass
The global service robotics market is experiencing strong growth, with various forecasts projecting market sizes from
A press release issued by AIBotics on August 12, 2025, incorrectly stated that the Company signed an agreement with a Singapore-based human-machine interface innovator to develop an autonomous operating platform to power our next generation of robots and AI assistants. The correct contracting party, as disclosed in our press release dated February 18, 2025, is Fort Lauderdale-based GMF Ventures, LLC.
About AIBotics
AIBotics, Inc. develops and manages AI- and robotics-enhanced technologies designed to solve real-world challenges. Its flagship product, the Phill Robot™, is an AI-powered massage robot that delivers spa-quality recovery with IoT integration. The Company is also focused on the next generation of artificial intelligence—systems capable of making independent decisions, managing complex tasks, and achieving outcomes without direct human input. To accelerate this vision, AIBotics has partnered to co-develop a next-generation autonomous operating platform.
Blending hardware expertise with a growing AI software stack, AIBotics is positioning itself as a leader in personal robotics, healthcare, wellness, and hospitality. The Company is expanding e-commerce distribution and pilot programs for Phill while also investing in R&D for its intelligent assistant platform.
For more information on AIBotics, visit https://www.aibotics.ai
About KEENON Robotics
Founded in 2010, KEENON Robotics is a globally renowned leader in service robotics, offering a comprehensive range of robots and integrated solutions. Since pioneering the first category of autonomous delivery robots, KEENON has continuously expanded into diverse sectors, introducing cleaning, guiding, disinfection, and other robots for catering, hotels, hospitals, factories, supermarkets, retail, entertainment, sports, and more. With locations in key international hubs like the U.S., Germany, U.A.E., Japan, South Korea, and Hong Kong S.A.R., KEENON Robotics extends its presence to over 60 countries and regions, spanning over 600 cities worldwide. For more information on KEENON Robotics, visit www.keenon.com
Forward-Looking Statement Disclaimer
This press release contains “forward-looking statements” within the meaning of applicable securities legislation. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions, opinions and estimates of management and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the U.S. Food and Drug Administration and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise, except as required by applicable law.
For Media and Investor Relations, please contact:
David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: dk@atlcp.com